financetom
Business
financetom
/
Business
/
Why Equitable Holdings (EQH) Shares Are Trading Higher
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Equitable Holdings (EQH) Shares Are Trading Higher
Feb 24, 2025 11:54 AM

Equitable Holdings Inc ( EQH ) shares are trading higher by 4.1% to $53.49 during Monday’s session after the company announced a cash tender offer for up to 46 million units of AllianceBernstein Holding LP ( AB ) at $38.50 per unit.

What To Know: Equitable Holdings, Inc. ( EQH ) has launched a cash tender offer to acquire up to 46 million units of AllianceBernstein Holding L.P. ( AB ) at $38.50 per unit, representing a 7.8% premium over AB's closing price on February 21, 2025.

Read Also: Equitable Inks Reinsurance Deal With RGA And Plans To Boost Stake In AllianceBernstein

The offer, totaling approximately $1.8 billion, seeks to increase Equitable's economic interest in AllianceBernstein ( AB ) from 61.9% to 77.5%.

What Else: Equitable, which currently holds no outstanding AB Holding units, aims to strengthen its position in AB, providing unitholders with an opportunity to liquidate their investments at a premium. If more than 46 million units are tendered, Equitable will purchase them on a pro-rata basis. Any units not accepted will be returned to investors.

The offer is set to expire on March 24, 2025, at 5 pm ET, unless extended. Any extension will be announced by 9 am ET the following business day.

Read Also: Palantir Extends Losses, Microsoft Slides: What’s Driving Markets Monday?

According to data from Benzinga Pro, EQH has a 52-week high of $56.00 and a 52-week low of $32.96.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...